Coronary Interventions Ulm - Coronary Chronic Total Occlusions
NCT ID: NCT04650139
Last Updated: 2020-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2014-01-01
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To investigate recanalization attempt of chronically occluded coronary arteries at the Ulm University Hospital. As shown, it is known that successful recanalization of a chronic occlusion is associated with a lower event rate (reduced mortality and the need for operative myocardial revascularization) compared to unsuccessful recanalization (drug therapy). The standard in the therapy of successfully recanalized chronic occlusions is the use of drug-releasing vascular supports.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
successful CTO
PCI - percutaneous coronary intervention
percutaneous coronary intervention
non- successful CTO
PCI - percutaneous coronary intervention
percutaneous coronary intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PCI - percutaneous coronary intervention
percutaneous coronary intervention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Coronary intervention in chronic coronary artery occlusion
Occlusion \> 3 months
Indication for PTCA or recanalization according to guidlines
such as:
Symptoms of the patient
Evidence of myocardial ischemia (stress ECG, scintigraphic
Methods, magnetic resonance imaging, stress echocardiography)
pathological intracoronary flow reserve, prognostic
Exclusion Criteria
* Contraindication to anti-platelet therapy
Acetylsalicylic acid plus clopidogrel for at least 3 months such as e.g.
with florid gastrointestinal ulcer disease,
History of hemorrhagic stroke
or urgent non-postponable surgical intervention.
Basic disease with a life expectancy of less than 12 months (here as a rule
no indication for PTCA or reopening available)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Ulm
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bruno Correia
Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Ulm
Ulm, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Bruno Correia
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0925-0586
Identifier Type: -
Identifier Source: org_study_id